Jonathan M Peacock's Net Worth
$46.2 Million
Who is Jonathan M Peacock?
Jonathan M Peacock has an estimated net worth of $46.2 Million. This is based on reported shares across multiple companies, which include AMGEN INC, Avantor, Inc., Bellerophon Therapeutics, Inc., Kite Pharma, Inc., and MICROMET, INC..
SEC CIK
Jonathan M Peacock's CIK is 0001500241
Past Insider Trading and Trends
2015 was Jonathan M Peacock's most active year for acquiring shares with 8 total transactions. Jonathan M Peacock's most active month to acquire stocks was the month of April. 2017 was Jonathan M Peacock's most active year for disposing of shares, totalling 7 transactions. Jonathan M Peacock's most active month to dispose stocks was the month of September. 2010 saw Jonathan M Peacock paying a total of $10,022,250.00 for 275,000 shares, this is the most they've acquired in one year. In 2017 Jonathan M Peacock cashed out on 146,184 shares for a total of $24,054,109.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMGEN INC (AMGN) Snapshot price: $295.795
EVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.14% | -13.04K |
$116.32 | -$1,517,394.40 | 94.41K |
Oct 28
| |||
Form 4
| -2.47% | -2.72K |
$104.93 | -$285,514.53 | 107.31K |
Apr 25
| |||
Form 4
| +7.30% | 7.48K |
—
|
—
| 109.95K |
Jan 28
| |||
Form 4
| -10.23% | -11.67K |
$87.63 | -$1,022,729.73 | 102.44K |
Oct 28
| |||
Form 4
| +8.21% | 8.65K |
—
|
—
| 114.03K |
Apr 27
| |||
Form 4
| -9.00% | -10.43K |
$58.06 | -$605,391.62 | 105.37K |
Oct 28
| |||
Form 4
| +15.80% | 15.8K |
—
|
—
| 115.8K |
Apr 25
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Oct 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Avantor, Inc. (AVTR) Snapshot price: $24
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.56% | 9.81K |
—
|
—
| 186.15K |
May 11
| |||
Form 4
| +3.95% | 6.69K |
—
|
—
| 176.34K |
May 12
| |||
Form 4
| +0.72% | 1.22K |
—
|
—
| 169.65K |
Apr 1
| |||
Form 4
| +4.49% | 7.24K |
—
|
—
| 168.43K |
Feb 25
| |||
Form 4
| +7.55% | 11.32K |
—
|
—
| 161.19K |
Feb 21
| |||
Form 4
| +1,340.46% | 132.14K |
—
|
—
| 142K |
May 21
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bellerophon Therapeutics, Inc. (BLPH) Snapshot price: $0.064
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.80% | 15.31K |
—
|
—
| 157.03K |
Mar 31
| |||
Form 4
| +18.66% | 350K |
—
|
—
| 2.23M |
Jan 23
| |||
Form 4
| +1.08% | 20K |
$0.61 | $12,198.00 | 1.88M |
May 21
| |||
Form 4
| +62.57% | 714.29K |
$0.70 | $500,000.20 | 1.86M |
Jan 25
| |||
Form 4
| +24.86% | 227.27K |
—
|
—
| 1.14M |
Jan 23
| |||
Form 4
| +12.14% | 99.01K |
—
|
—
| 914.36K |
Apr 2
| |||
Form 4
| +43.96% | 248.96K |
—
|
—
| 815.35K |
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 4
| +11.40% | 57.97K |
—
|
—
| 566.39K |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
| +128.29% | 285.71K |
—
|
—
| 508.42K |
Nov 29
| |||
Form 4
| +2.30% | 5K |
$1.37 | $6,841.50 | 222.7K |
May 17
| |||
Form 4
| +320.87% | 165.97K |
—
|
—
| 217.7K |
Jan 25
| |||
Form 4
| +64.59% | 20.3K |
$2.75 | $55,735.68 | 51.73K |
Dec 15 - Dec 16
| |||
Form 4
| +18.92% | 5K |
$5.48 | $27,377.00 | 31.43K |
Aug 19
| |||
Form 4
| +26.64% | 5.56K |
$8.69 | $48,323.07 | 26.43K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
| +31,044.78% | 20.8K |
$12.00 | $249,600.00 | 20.87K |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kite Pharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -70.37K |
$180.00 |
—
|
0
|
Sep 13 - Oct 3
| |||
Form 4
| +3.55% | 2.41K |
—
|
—
| 70.37K |
Jun 20
| |||
Form 4
| +2.95% | 1.95K |
—
|
—
| 67.96K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
∞
| 66.01K |
$15.30 | $1,010,014.20 | 66.01K |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MICROMET, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||